Canaccord Genuity reaffirms Buy rating on Apogee Therapeutics stock after positive trial data

3 days ago 1
Read Entire Article
  1. Homepage
  2. Finance
  3. Canaccord Genuity reaffirms Buy rating on Apogee Therapeutics stock after positive trial data

Related

SA analyst upgrades/downgrades: CVX, TLRY, LULU, REGN

SA analyst upgrades/downgrades: CVX, TLRY, LULU, REGN

12 minutes ago 0
15 breakout winners in 2025’s worst-performing S&P sector

15 breakout winners in 2025’s worst-performing S&P sector

16 minutes ago 0
The Rise of the Everyday Millionaire, or the EMILLI

The Rise of the Everyday Millionaire, or the EMILLI

23 minutes ago 0
Franklin Street Properties declares $0.01 dividend

Franklin Street Properties declares $0.01 dividend

24 minutes ago 0
Casino stocks trade lower after state gaming revenue reports disappoint

Casino stocks trade lower after state gaming revenue reports...

25 minutes ago 0
Coinbase acquires leadership team of DeFi project Opyn Markets

Coinbase acquires leadership team of DeFi project Opyn Marke...

36 minutes ago 0
Albemarle cut to Sell at UBS, seeing continued lithium glut

Albemarle cut to Sell at UBS, seeing continued lithium glut

44 minutes ago 0
Pershing Square CEO Bill Ackman made his professional tennis debut. He lasted 67 minutes.

Pershing Square CEO Bill Ackman made his professional tennis...

46 minutes ago 0
Robinhood faces Florida AG probe for allegedly misrepresenting crypto pricing

Robinhood faces Florida AG probe for allegedly misrepresenti...

59 minutes ago 0
Market Voices: Canadian tariffs, OMB eyes Powell probe, Hasbro prices

Market Voices: Canadian tariffs, OMB eyes Powell probe, Hasb...

1 hour ago 0
GameStop is auctioning off the stapler that broke Nintendo Switch 2 consoles and its CEO’s undergarments—and bidding has topped $200K

GameStop is auctioning off the stapler that broke Nintendo S...

1 hour ago 0
Top Seeking Alpha tech sector Quant picks ahead of Q2 earnings

Top Seeking Alpha tech sector Quant picks ahead of Q2 earnin...

1 hour ago 0
SA Asks: What lies ahead for chip tech provider Wolfspeed?

SA Asks: What lies ahead for chip tech provider Wolfspeed?

1 hour ago 0
Box office collection for Gunn's Superman to soar above $200M

Box office collection for Gunn's Superman to soar above $200...

1 hour ago 0
Lumentum, Coherent, Fabrinet to benefit from growing optical transceiver market

Lumentum, Coherent, Fabrinet to benefit from growing optical...

1 hour ago 0
As tech CEOs predict AI will replace humans in just 5 years, this Fortune 500 boss says taking the focus off real people is a ‘recipe for failure’ 

As tech CEOs predict AI will replace humans in just 5 years,...

1 hour ago 0
HPE targets $600M in cost synergies over next three years on Juniper acquisition

HPE targets $600M in cost synergies over next three years on...

1 hour ago 0
BP rises on surprisingly upbeat Q2 production and oil trading guidance

BP rises on surprisingly upbeat Q2 production and oil tradin...

1 hour ago 0
Top rated and bottom rated stocks according to 3 key drivers of performance – UBS

Top rated and bottom rated stocks according to 3 key drivers...

1 hour ago 0
Newegg Commerce's FantasTech Sale fuels 4-day rally

Newegg Commerce's FantasTech Sale fuels 4-day rally

1 hour ago 0

Trending

1. italy
2. income tax excel utility
3. amazon prime day
4. bjorn borg
5. air india boeing 787 crash
6. narivetta ott release date
7. moon
8. novak djokovic
9. wimbledon winners
10. बारिश की चेतावनी

Popular

TechCrunch Mobility: The state of EV sales and Rivian secures the next $1B from VW

TechCrunch Mobility: The state of EV sales and Rivian secure...

1 week ago 8
Castelion raises $350M Series B to scale hypersonic missile business

Castelion raises $350M Series B to scale hypersonic missile ...

1 week ago 6
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© FBT Company 2025. All rights are reserved